Teva Stops Selling Generic Univasc
This article was originally published in The Pink Sheet Daily
Agreement with Schwarz ends at-risk launch of the antihypertensive moexipril. Teva launched the generic in May 2003 after receiving a favorable patent ruling in federal district court.
You may also be interested in...
Teva plans to continue distributing its generic version of Schwarz' Univasc despite an appeals court's Jan. 29 opinion vacating a noninfringement ruling for the company
Our infographic offers a composite sketch from a decade of US FDA data on refuse-to-file letters.
Pink Sheet reporters and editor discuss the issues surrounding an FDA warning letter on Dsuvia promotion, an expected jump in CDER coronavirus-related workload, and a study of refuse-to-file actions.